Orchestra BioMed Completes Enrollment in BACKBEAT Pivotal Trial
Orchestra BioMed exceeded its target of 316 patients by completing enrollment in the BACKBEAT pivotal trial of AVIM Therapy for pacemaker-indicated patients with uncontrolled hypertension. The trial was conducted in partnership with Medtronic.